Published articles

Published articles 1 records found  Search took 0.00 seconds. 
1.
12 p, 2.1 MB EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer / Serrano, Maria J. (Universidad of Granada. Departamento de Medicina Legal) ; Ortega, Francisco G. (GENYO. Pfizer-) ; Alvarez-Cubero, Maria J. (Universidad de Granada. Departamento de Medicina Legal) ; Nadal Rios, Rosa (Hospital de Barcelona) ; Sanchez-Rovira, Pedro (Universidad de Jaén) ; Salido, Marta (Institut Hospital del Mar d'Investigacions Mèdiques) ; Rodríguez, María (Institut Hospital del Mar d'Investigacions Mèdiques) ; García-Puche, José Luis (GENYO. Pfizer-) ; Delgado-Rodríguez, Miguel (Universidad de Jaen. CIBERESP) ; Solé, Francisco (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; García, Maria A. (Complejo Hospitalario Universitario de Granada) ; Perán, Macarena (Universidad de Granada. Instituto de Biopatología y Medicina Regenerativa) ; Rosell, Rafael (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Marchal, Juan A. (Universidad de Granada. Departamento de Anatomía y Embriología Humana) ; Lorente, Jose A. (Universidad de Granada. Departamento de Medicina Legal) ; Universitat Autònoma de Barcelona
Circulating tumor cells (CTCs) are frequently associated with epithelialmesenchymal transition (EMT). The objective of this study was to detect EMT phenotype through Vimentin (VIM) and Slug expression in cytokeratin (CK)-negative CTCs in non-metastatic breast cancer patients and to determine the importance of EGFR in the EMT phenomenon. [...]
2014 - 10.18632/oncotarget.2217
Oncotarget, Vol. 5 (july 2014) , p. 7486-7497  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.